Immunoassay Market (By Product: Reagents & Kits, Analyzer, Software and Services; By Technology: ELISA, Rapid Tests, ELISpot, Western Blotting, Radioimmunoassay; By Specimen: Blood, Saliva, Urine, Other; By Application: Infectious diseases, Endocrinology, Oncology, Bone And Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Immunoassay Market 

5.1. COVID-19 Landscape: Immunoassay Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Immunoassay Market, By Product

8.1. Immunoassay Market, by Product, 2023-2032

8.1.1. Reagents & Kits

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Analyzer

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Software and Services

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Immunoassay Market, By Technology

9.1. Immunoassay Market, by Technology, 2023-2032

9.1.1. ELISA

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Rapid Tests

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. ELISpot

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Western Blotting

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Radioimmunoassay

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Other technologies

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Immunoassay Market, By Specimen 

10.1. Immunoassay Market, by Specimen, 2023-2032

10.1.1. Blood

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Saliva

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Urine

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Other Specimen

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Immunoassay Market, By Application

11.1. Immunoassay Market, by Application, 2023-2032

11.1.1. Infectious diseases

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Endocrinology

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Oncology

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Bone and mineral disorders

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Cardiology

11.1.5.1. Market Revenue and Forecast (2020-2032)

11.1.6. Blood screening

11.1.6.1. Market Revenue and Forecast (2020-2032)

11.1.7. Autoimmune Disorders

11.1.7.1. Market Revenue and Forecast (2020-2032)

11.1.8. Allergy Diagnostics

11.1.8.1. Market Revenue and Forecast (2020-2032)

11.1.9. Toxicology

11.1.9.1. Market Revenue and Forecast (2020-2032)

11.1.10. Newborn Screening

11.1.10.1. Market Revenue and Forecast (2020-2032)

11.1.11. Other Application

11.1.11.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Immunoassay Market, By End-User

12.1. Immunoassay Market, by End-User, 2023-2032

12.1.1. Hospitals & Clinics

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Clinical Laboratories

12.1.2.1. Market Revenue and Forecast (2020-2032)

12.1.3. Pharmaceutical & Biotechnology Companies And Cro

12.1.3.1. Market Revenue and Forecast (2020-2032)

12.1.4. Blood Banks

12.1.4.1. Market Revenue and Forecast (2020-2032)

12.1.5. Research & Academic Laboratories

12.1.5.1. Market Revenue and Forecast (2020-2032)

12.1.6. Home Care Setting

12.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global Immunoassay Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product (2020-2032)

13.1.2. Market Revenue and Forecast, by Technology (2020-2032)

13.1.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.1.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.5. Market Revenue and Forecast, by End-User (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.1.6.2. Market Revenue and Forecast, by Technology (2020-2032)

13.1.6.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.1.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.6.5. Market Revenue and Forecast, by End-User (2020-2032) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product (2020-2032)

13.1.7.2. Market Revenue and Forecast, by Technology (2020-2032)

13.1.7.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.1.7.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.7.5. Market Revenue and Forecast, by End-User (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.2. Market Revenue and Forecast, by Technology (2020-2032)

13.2.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.2.4. Market Revenue and Forecast, by Application (2020-2032) 

13.2.5. Market Revenue and Forecast, by End-User (2020-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)

13.2.6.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.2.7. Market Revenue and Forecast, by Application (2020-2032) 

13.2.8. Market Revenue and Forecast, by End-User (2020-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.9.2. Market Revenue and Forecast, by Technology (2020-2032)

13.2.9.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.2.10. Market Revenue and Forecast, by Application (2020-2032)

13.2.11. Market Revenue and Forecast, by End-User (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.12.2. Market Revenue and Forecast, by Technology (2020-2032)

13.2.12.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.2.12.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.13. Market Revenue and Forecast, by End-User (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product (2020-2032)

13.2.14.2. Market Revenue and Forecast, by Technology (2020-2032)

13.2.14.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.2.14.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.15. Market Revenue and Forecast, by End-User (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.2. Market Revenue and Forecast, by Technology (2020-2032)

13.3.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.3.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.5. Market Revenue and Forecast, by End-User (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)

13.3.6.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.3.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.7. Market Revenue and Forecast, by End-User (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.8.2. Market Revenue and Forecast, by Technology (2020-2032)

13.3.8.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.3.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.9. Market Revenue and Forecast, by End-User (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.10.2. Market Revenue and Forecast, by Technology (2020-2032)

13.3.10.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.3.10.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.10.5. Market Revenue and Forecast, by End-User (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product (2020-2032)

13.3.11.2. Market Revenue and Forecast, by Technology (2020-2032)

13.3.11.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.3.11.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.11.5. Market Revenue and Forecast, by End-User (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.2. Market Revenue and Forecast, by Technology (2020-2032)

13.4.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.4.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.5. Market Revenue and Forecast, by End-User (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)

13.4.6.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.4.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.7. Market Revenue and Forecast, by End-User (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.8.2. Market Revenue and Forecast, by Technology (2020-2032)

13.4.8.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.4.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.9. Market Revenue and Forecast, by End-User (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.10.2. Market Revenue and Forecast, by Technology (2020-2032)

13.4.10.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.4.10.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.10.5. Market Revenue and Forecast, by End-User (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product (2020-2032)

13.4.11.2. Market Revenue and Forecast, by Technology (2020-2032)

13.4.11.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.4.11.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.11.5. Market Revenue and Forecast, by End-User (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product (2020-2032)

13.5.2. Market Revenue and Forecast, by Technology (2020-2032)

13.5.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.5.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.5. Market Revenue and Forecast, by End-User (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

13.5.6.2. Market Revenue and Forecast, by Technology (2020-2032)

13.5.6.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.5.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.7. Market Revenue and Forecast, by End-User (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product (2020-2032)

13.5.8.2. Market Revenue and Forecast, by Technology (2020-2032)

13.5.8.3. Market Revenue and Forecast, by Specimen (2020-2032)

13.5.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.8.5. Market Revenue and Forecast, by End-User (2020-2032)

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Danaher Corporation (Beckman Coulter)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Quidel Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Ortho Clinical Diagnostics

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Sysmex Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Bio-Rad Laboratories, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Becton, Dickinson, and Company

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. F. Hoffmann-La Roche AG

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Thermo Fisher Scientific, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Siemens Healthinners

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample